QNTM
Quantum BioPharma Ltd.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$30.76M
P/E Ratio
—
EPS
$-7.68
Beta
0.36
52W High
$38.25
52W Low
$2.07
50-Day MA
$3.64
200-Day MA
$10.49
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Quantum BioPharma Ltd.
Quantum BioPharma Ltd. (QNTM) is a forward-thinking biotechnology firm dedicated to creating transformative therapies for challenging medical conditions, with a particular focus on oncology and autoimmune diseases. The company boasts a promising pipeline of innovative biopharmaceuticals, underpinned by advanced technologies and a strong commitment to research and development. Supported by strategic collaborations and an experienced leadership team, Quantum BioPharma is well-positioned to meet the escalating demand for novel therapeutics, making it an attractive proposition for institutional investors navigating the evolving biopharmaceutical sector.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-14.76M |
| Operating Margin | 0.00% |
| Return on Equity | -346.90% |
| Return on Assets | -67.60% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $1.78 |
| Price-to-Book | 4.67 |
| Price-to-Sales (TTM) | 106.31 |
| EV/Revenue | 335.68 |
| EV/EBITDA | -1.57 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $5.83M |
| Float | $5.36M |
| % Insiders | 20.35% |
| % Institutions | 15.54% |
More HEALTHCARE Stocks
Data last updated: 5/5/2026